Search results
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 2 days agoRival developers of Covid-19 jabs have faced off at the High Court in London as a weeks-long trial...
Pfizer (NYSE:PFE) Trading 0.9% Higher
ETF DAILY NEWS· 4 days agoShares of Pfizer Inc. (NYSE:PFE – Get Free Report) traded up 0.9% during mid-day trading on Friday . The stock traded as high as $25.66 and last traded at $25.62. 10,092,678 ...
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...
Benzinga· 2 days agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Pfizer Vs Moderna Battle Over COVID Vaccine Patents Begins in UK
US News & World Report· 2 days agoPfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines for COVID-19, as the latest leg of a global legal ...
WPP Reports Revenue Hit From Tech Pullback
The Wall Street Journal· 1 hour agoHowever, WPP said spending cuts at tech companies and the loss of Pfizer creative duties weighed on the results of its global integrated agencies, while...
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
InvestorPlace· 23 hours agoIn the changing environment of 2024, astute investors have a plethora of options to strengthen their...
Pfizer Options Trading: A Deep Dive into Market Sentiment - Pfizer (NYSE:PFE)
Benzinga· 3 days agoLoading... Loading... Financial giants have made a conspicuous bullish move on Pfizer. Our analysis of options history for Pfizer PFE revealed 18 unusual ...
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
Zacks· 6 days agoFree Report) is one of the stocks most watched by Zacks.com visitors lately. The Zacks Large Cap Pharmaceuticals industry, to which Pfizer belongs, has lost 4.1% over this ...
U.S. regulators give full approval to Pfizer COVID-19 vaccine
AOL· 6 days agoThe U.S. gave full approval to Pfizer's COVID-19 vaccine on Monday, a milestone that may help lift public confidence in the shots as the nation battles the most contagious ...
Levi Strauss, Pfizer, Goldman Sachs and Cigna Face Challenges from Conservative Shareholders
National Center for Public Policy Research· 2 days agoProposals Target Donations to Radical Causes, Net Zero Plans and DEI Programs Washington, D.C. – Shareholder activists with the National Center for Public Policy Research’s Free Enterprise Project ...